
William Y. Kim
@williamkimmd
Prof of Med, Gen, Pharm UNC Chapel Hill. Physician-scientist, @wesleyan_u @BrownMedicine @BIDMC_IM @DanaFarber Alum. Working to cure #bladdercancer & #RCC.
ID: 1938293942
https://unclineberger.org/kimlab/ 05-10-2013 17:15:57
575 Tweet
1,1K Followers
1,1K Following


Results from the #AMBASSADOR study presented at #GU24 by Andrea Apolo, M.D. evaluated the role of adjuvant #pembrolizumab following surgical resection for #MIUC. Learn more: buff.ly/492uXek


#WorldCancerDay OncoAlert Fred Hutch Cancer Center I plan to keep working hard to “close the gap” & reduce disparities in oncology: prevention, diagnosis, therapy, survivorship! Julie Gralow Clifford Hudis Dr. Tom Lynch Eric J. Small, MD, FASCO Oncology Brothers World Bladder Cancer Patient Coalition Bladder Cancer Advocacy Network Karima Oualla, MD,MSc



Thank you Markus Eckstein but note that the credit all goes to Kristin Weiss Kathryn Hacker Gessner and Marc A. Bjurlin #Plasmacytoid definitely an interesting entity.

Happy Friday! Happy Chinese New Year! Happy to share that our final version of our paper Modern Pathology is now available online at the following link: sciencedirect.com/science/articl… Congrats to Dr. Posada, our former Brown Pathology and Laboratory Medicine fellow, and our spectacular international team





Join @BladdercancerUS and CDMRP to talk about #researchfunding opportunities 4.17.24 noon(ET)! Tell colleagues too Dr. Bishoy M. Faltas Petros Grivas Max Kates Ashish M. Kamat, MD, MBBS Matt Nielsen, MD Rich Matulewicz Guru P. Sonpavde, MD Matt Milowsky William Y. Kim Stephen B. Williams, MD, MBA, MS, FACHE ...

jci.org/articles/view/… Delighted to share our recent publication Journal of Clinical Investigation on the new function of VHL on regulating m6A signaling and mRNA stability in ccRCC tumorigenesis. 1/n


Check out our correlative analysis of the LCCC1520 clinical trial of neoadjuvant chemo-immunotherapy for muscle-invasive #bladdercancer, now published in Nature Communications. Special thanks to Personalized Immunotherapy Research Lab, the Kim Lab, and all members of the project team! nature.com/articles/s4146…

Great job by Wolfgang Beckabir leading a fun and productive collaboration! Nature Communications Benjamin Vincent William Y. Kim Matt Milowsky UNC Lineberger UNC Microbiology and Immunology Department nature.com/articles/s4146…

Thrilled to welcome the incredible Apoorv Dhir to the UNC Urologic Oncology Program team! #SUOmatch #GoHeels 🤝 #GoBlue


New insights into the biology of kidney cancer, including those informed by scientific discoveries that earned a Nobel Prize, have led to advances in treatment and increased survival rates, according to a review by UNC Lineberger’s William Y. Kim, and Tracy L. Rose, MD, MPH.

Huge congrats to Andrea Apolo, M.D. Guru P. Sonpavde, MD Jonathan Rosenberg MD William Y. Kim Stephanie Berg & the Alliance for Clinical Trials in Oncology team on a terrific ESMO - Eur. Oncology presentation & a concomitant NEJM paper! A very exciting #ESMO24 indeed!


I am proud that Bladder Cancer Bladder Cancer is in its 10th year of publication and it is now fully indexed in Pubmed! The journal is also Open Access making its cutting-edge articles on #bladdercancer freely available. PubMed Online bladdercancerjournal.com


What is the impact of sex on outcomes in NMIBC? Check out our latest study in European Urology Oncology led by Niyati Lobo MD Anderson Cancer Center #OncSurgery 🧵/1 authors.elsevier.com/a/1j%7E6A9Cfv-… @sood11 Sia Viborg Lindskrog Stephen B. Williams, MD, MBA, MS, FACHE Lars Dyrskjøt Kelly Bree #SIU2024 #SIU2024NewDelhi World Bladder Cancer Patient Coalition
